- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05835401
Effects of Dietary Nitrate Intake on Cardiovascular Performance in Response to Hand Grip Test in Bodybuilders
July 23, 2025 updated by: Cicero Jonas R Benjamim, University of Sao Paulo
Through a randomized, crossover, double-blind, placebo-controlled clinical trial, 20 bodybuilders will participate a acute-day trial with two intervention protocols: 1) placebo and 2) nitrate; in which will ingest beet juice with or without NO3 in its composition with a 7-day washout interval.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Ribeirão Preto, São Paulo, Brazil
- EEFERP - USP / Laboratório de Fisiologia do Exercício e Metabolismo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Anabolic steroid use in the past or actually;
- Participation at least one bodybuilding competition;
Exclusion Criteria:
- Previous history of acute myocardial infarction and/or stroke;
- Allergy or intolerance to nitrate, gluten, or milk;
- Medications (proton pump inhibitors, beta-blockers, calcium channels antagonists).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental (Beetroot juice NO3)
Acute ingestion of beetroot juice rich in NO3 (800mg).
|
The participant will intake beetroot juice rich in NO3 (800mg).
Two hours after intake the last bottle of juice, the participants will go to the laboratory for the handgrip and cardiovascular tests evaluation.
Before crossover protocol a 7-day washout interval will be given for the purification of the compounds provided by the protocols.
|
|
Placebo Comparator: Placebo (Beetroot juice without NO3)
Acute ingestion of beetroot juice rich depleted in NO3.
|
The participant will intake beetroot juice depleted in NO3.
Two hours after intake the last bottle of juice, the participants will go to the laboratory for the handgrip and cardiovascular tests evaluation.
Before crossover protocol a 7-day washout interval will be given for the purification of the compounds provided by the protocols.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
1. Values of systolic and diastolic blood pressure (mmHg)
Time Frame: up to 2 years
|
up to 2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Values of heart rate variability (ms)
Time Frame: up to 2 years
|
up to 2 years
|
|
Values of heart rate (beats per minute)
Time Frame: up to 2 years
|
up to 2 years
|
|
Plasmatic concentrations of nitrate and nitrite (mmol/L)
Time Frame: up to 2 years
|
up to 2 years
|
|
Macrovascular function (Flow mediated dilatation%)
Time Frame: up to 2 years
|
up to 2 years
|
|
Values of hand grip strength (kgF)
Time Frame: up to 2 years
|
up to 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Cicero Jonas Rodrigues Benjamim, PhD Student, University of Sao Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 17, 2023
Primary Completion (Actual)
December 31, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
April 18, 2023
First Submitted That Met QC Criteria
April 18, 2023
First Posted (Actual)
April 28, 2023
Study Record Updates
Last Update Posted (Actual)
July 28, 2025
Last Update Submitted That Met QC Criteria
July 23, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BodyBeet
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Abnormalities
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedAbnormalities, CardiovascularUnited States
-
University of California, DavisTerminatedAbnormalities, Cardiovascular
-
Federal University of Minas GeraisUppsala UniversityNot yet recruitingCardiovascular Abnormalities | Electrocardiogram
-
Institute of Oncology LjubljanaUniversity Medical Centre LjubljanaNot yet recruiting
-
BayerCompleted
-
Soroka University Medical CenterCompletedCardiovascular Abnormalities | Hemodynamic Instability | Respiratory AbnormalitiesIsrael
-
Ain Shams UniversityCompletedVascular MalformationEgypt
-
Cliniques universitaires Saint-Luc- Université...CompletedCardiovascular AbnormalitiesBelgium
-
CargillAjinomoto Co., Inc.CompletedCardiovascular Abnormalities
-
Medical College of WisconsinChildren's National Research InstituteCompleted
Clinical Trials on Beetroot juice rich in nitrate
-
University of Sao PauloRecruitingMotor Activity | Physical Inactivity | Postmenopausal; MenorrhagiaBrazil
-
University of Sao PauloRecruitingCardiovascular Diseases | Arterial Hypertension | Postmenopausal; MenorrhagiaBrazil
-
University of Colorado, BoulderActive, not recruitingChronic Kidney DiseaseUnited States
-
Oxford Brookes UniversityNot yet recruitingHypertension | Type 2 Diabetes Mellitus | Autonomic Nervous System DiseasesUnited Kingdom
-
University of FloridaCompletedCoronary Artery DiseaseUnited States
-
University of ExeterCompletedCognitive Change | Blood Pressure | Functional Capacity | Brain MetabolismUnited Kingdom
-
Bangor UniversityCompleted
-
Newcastle UniversityNot yet recruitingHeart Failure With Reduced Ejection Fraction
-
University of VirginiaNot yet recruitingCoronary Microvascular Dysfunction (CMD) | Angina Patients With Non-obstructive Coronary Artery DiseaseUnited States
-
University of ReadingSaudi Cultural BureauCompletedNo Dental Disease | Non-smokingUnited Kingdom